Intended for healthcare professionals

Rapid response to:


Tony Gershlick: pioneering cardiologist

BMJ 2020; 371 doi: (Published 11 December 2020) Cite this as: BMJ 2020;371:m4808

Rapid Response:

Re: Tony Gershlick: pioneering cardiologist

Dear Editor

Professor Tony Gershlick’s obituary was, in many respects, a wonderful tribute ( It is important to add, however, that Tony’s research career was accelerating in both scale and impact during the last ten years of his life. For example, he led CvLPRIT (Complete versus Lesion-only Primary PCI trial) that demonstrated a benefit in treating bystander disease in addition to the culprit artery in STEMI, altering the way clinicians considered how such patients should be managed. This trial was central in changing international clinical guidelines and it formed the basis of an outstanding Impact Case Study for REF 2014. Its continuing impact has resulted in a follow on case study for REF 2021.

In December 2017, Tony secured an EU Horizon 2020 grant, EURO SHOCK, worth 6.5 million euros. This is a collaborative international trial comparing outcomes with early ECMO versus standard of care in patients with cardiogenic shock following Acute Coronary Syndrome. In addition, I know Tony had already mapped out at least two further trials, and was designing a novel stent. He was fizzing with new research ideas.

There is also a personal clarification to add. Tony separated from Mary over ten years ago. He also leaves two much loved sisters, Janet and Pat, friends, neighbours, fellow enthusiasts from the Leicester Jazz scene, and me, his partner and soulmate. Each summer in his village, Tony staged a charity event: 'Jazz on the Green'. He even persuaded me, and his sister Janet, to sing (!). We are hoping to run the event again this summer in his memory. His Jazz friends are all ready and waiting to play.

Competing interests: No competing interests

04 March 2021
Kathy M. Armour
University of Birmingham
Oakham, Rutland.